UnitedHealth Group Incorporated with ticker code (UNH) have now 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $622.49 and $433.44 suggesting an average analyst share price target price of $553.31. (at the time of writing). Given that the stocks previous close was at $504.54 and the analysts are correct then there would likely be a percentage uptick in value of 9.7%. Also worth taking note is the 50 day moving average now sits at $531.20 and the 200 moving average now moves to $506.39. The market capitalization for the company is 465.80B. The current share price for the company is: $503.61 USD
The potential market cap would be $510,826,887,345 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 21.1, revenue per share of $396.19 and a 7.79% return on assets.
UnitedHealth Group Incorporated is a diversified health care company that operates Optum and UnitedHealthcare platforms. Its segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health segment is focused on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Insight segment serves the needs of hospital systems, physicians, health plans, governments and life sciences companies. Optum Rx segment offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. UnitedHealthcare includes the combined results of operations of UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global.
